Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis

Journal of the American College of Cardiology

Volumn 71, Issue 8, 2018, Pages 860-871

  Treibel, Thomas A ^a,b   Kozor, Rebecca ^a   Schofield, Rebecca ^a   Benedetti, Giulia ^a   Fontana, Marianna ^b   Bhuva, Anish N ^a,b   Sheikh, Amir ^a   López, Begoña ^c,d,e   González, Arantxa ^c,d,e   Manisty, Charlotte ^a,b   Lloyd, Guy ^a,b   Kellman, Peter ^f   Díez, Javier ^c,d,e,g   Moon, James C ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NAVARRA   (Spain)

^d Recinto de Complejo Hospitalario de Navarra   (Spain)

^e Carlos III National Institute of Health ^*  (Spain)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

aortic stenosis; fibrosis; left ventricular hypertrophy

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

ADULT; AGED; AORTIC STENOSIS; AORTIC VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CELL VOLUME; COHORT ANALYSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM REMODELING; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIX MINUTE WALK TEST;

EID: 85044535810     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.12.035     Document Type: Article

References (48)

1. Nkomo, V.T., Gardin, J.M., Skelton, T.N., Gottdiener, J.S., Scott, C.G., Enriquez-Sarano, M., Burden of valvular heart diseases: a population-based study. Lancet 368 (2006), 1005–1011.
2. Houser, S.R., Margulies, K.B., Murphy, A.M., et al. Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res 111 (2012), 131–150.
3. Azevedo, C.F., Nigri, M., Higuchi, M.L., et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 56 (2010), 278–287.
4. Dweck, M.R., Joshi, S., Murigu, T., et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 58 (2011), 1271–1279.
5. Barone-Rochette, G., Pierard, S., De Meester de Ravenstein, C., et al. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol 64 (2014), 144–154.
6. Weidemann, F., Herrmann, S., Stork, S., et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 120 (2009), 577–584.
7. Herrmann, S., Stork, S., Niemann, M., et al. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. J Am Coll Cardiol 58 (2011), 402–412.
8. Yarbrough, W.M., Mukherjee, R., Ikonomidis, J.S., Zile, M.R., Spinale, F.G., Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications. J Thorac Cardiovasc Surg 143 (2012), 656–664.
9. Lim, E., Ali, A., Theodorou, P., et al. Longitudinal study of the profile and predictors of left ventricular mass regression after stentless aortic valve replacement. Ann Thorac Surg 85 (2008), 2026–2029.
10. Beach, J.M., Mihaljevic, T., Rajeswaran, J., et al. Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 147 (2014), 362–369.e8.
11. Lamb, H.J., Beyerbacht, H.P., de Roos, A., et al. Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation. J Am Coll Cardiol 40 (2002), 2182–2188.
12. Pinto, A.R., Ilinykh, A., Ivey, M.J., et al. Revisiting cardiac cellular composition. Circ Res 118 (2016), 400–409.
13. Maestrini, V., Treibel, T.A., White, S.K., Fontana, M., Moon, J.C., T1 mapping for characterization of intracellular and extracellular myocardial diseases in heart failure. Curr Cardiovasc Imaging Rep, 7, 2014, 9287.
14. Flett, A.S., Hayward, M.P., Ashworth, M.T., et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122 (2010), 138–144.
15. Cioffi, G., Faggiano, P., Vizzardi, E., et al. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart 97 (2011), 301–307.
16. Ali, A., Patel, A., Ali, Z., et al. Enhanced left ventricular mass regression after aortic valve replacement in patients with aortic stenosis is associated with improved long-term survival. J Thorac Cardiovasc Surg 142 (2011), 285–291.
17. Mihaljevic, T., Nowicki, E.R., Rajeswaran, J., et al. Survival after valve replacement for aortic stenosis: implications for decision making. J Thorac Cardiovasc Surg 135 (2008), 1270–1278 discussion 1278–9.
18. Nadjiri, J., Nieberler, H., Hendrich, E., et al. Prognostic value of T1-mapping in TAVR patients: extra-cellular volume as a possible predictor for peri- and post-TAVR adverse events. Int J Cardiovasc Imaging 32 (2016), 1625–1633.
19. Chin, C.W., Everett, R.J., Kwiecinski, J., et al. Myocardial fibrosis and cardiac decompensation in aortic stenosis. J Am Coll Cardiol Img 10 (2016), 1320–1333.
20. Schwarz, F., Flameng, W., Schaper, J., et al. Myocardial structure and function in patients with aortic valve disease and their relation to postoperative results. Am J Cardiol 41 (1978), 661–669.
21. Villari, B., Vassalli, G., Monrad, E.S., Chiariello, M., Turina, M., Hess, O.M., Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation 91 (1995), 2353–2358.
22. Castillo-Moreno, J.A., Garcia-Escribano, I.A., Martinez-Pascual-de-Riquelme, M., et al. Prognostic usefulness of the 6-minute walk test in patients with severe aortic stenosis. Am J Cardiol 118 (2016), 1239–1243.
23. Baumgartner, H., Hung, J., Bermejo, J., et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 10 (2009), 1–25.
24. Kellman, P., Arai, A.E., Xue, H., T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision. J Cardiovasc Magn Reson, 15, 2013, 56.
25. Maceira, A.M., Prasad, S.K., Khan, M., Pennell, D.J., Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8 (2006), 417–426.
26. Moon, J.C., Messroghli, D.R., Kellman, P., et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson, 15, 2013, 92.
27. Treibel, T.A., Fontana, M., Gilbertson, J.A., et al. Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging, 9, 2016, e005066.
28. Krayenbuehl, H.P., Hess, O.M., Monrad, E.S., Schneider, J., Mall, G., Turina, M., Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 79 (1989), 744–755.
29. Hess, O.M., Ritter, M., Schneider, J., Grimm, J., Turina, M., Krayenbuehl, H.P., Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 69 (1984), 855–865.
30. Flett, A.S., Sado, D.M., Quarta, G., et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 13 (2012), 819–826.
31. Jalil, J.E., Doering, C.W., Janicki, J.S., Pick, R., Shroff, S.G., Weber, K.T., Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64 (1989), 1041–1050.
32. Treibel, T.A., López, B., González, A., et al. Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients. Eur Heart J, 2017 Jul 22 [E-pub ahead of print].
33. Devereux, R.B., Devereux, R.B., Dahlöf, B., et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 110 (2004), 1456–1462.
34. Dahl, J.S., Videbaek, L., Poulsen, M.K., et al. Effect of candesartan treatment on left ventricular remodeling after aortic valve replacement for aortic stenosis. Am J Cardiol 106 (2010), 713–719.
35. Bull, S., Loudon, M., Francis, J.M., et al. A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial). Eur Heart J Cardiovasc Imaging 16 (2015), 834–841.
36. Butler, J., Fonarow, G.C., Gheorghiade, M., Strategies and opportunities for drug development in heart failure. JAMA 309 (2013), 1593–1594.
37. Fairbairn, T.A., Steadman, C.D., Mather, A.N., et al. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart 99 (2013), 1185–1191.
38. Swynghedauw, B., Molecular mechanisms of myocardial remodeling. Physiol Rev 79 (1999), 215–262.
39. Weber, K.T., Sun, Y., Bhattacharya, S.K., Ahokas, R.A., Gerling, I.C., Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10 (2013), 15–26.
40. Singh, A., Greenwood, J.P., Berry, C., et al. Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) Study. Eur Heart J 38 (2017), 1222–1229.
41. Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2438–2488.
42. Lindman, B.R., Stewart, W.J., Pibarot, P., et al. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. J Am Coll Cardiol Intv 7 (2014), 662–673.
43. Monrad, E.S., Monrad, E.S., Hess, O.M., et al. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation 77 (1988), 1345–1355.
44. Mahmod, M., Piechnik, S.K., Levelt, E., et al. Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values. J Cardiovasc Magn Reson, 16, 2014, 92.
45. Rakusan, K., Flanagan, M.F., Geva, T., Southern, J., Van Praagh, R., Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 86 (1992), 38–46.
46. Laine, G.A., Allen, S.J., Left ventricular myocardial edema: lymph flow, interstitial fibrosis, and cardiac function. Circ Res 68 (1991), 1713–1721.
47. Kellman, P., Wilson, J.R., Xue, H., et al. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson, 14, 2012, 64.
48. McDiarmid, A.K., Swoboda, P.P., Erhayiem, B., et al. Athletic cardiac adaptation in males is a consequence of elevated myocyte mass. Circ Cardiovasc Imaging, 9, 2016, e003579.